MS
DGX icon

Millington Securities’s Quest Diagnostics DGX Stock Holding History

Millington Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.19M Buy
+6,057
New +$1.18M 0.33% 82

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Millington Securities's DGX Position: Q1 2026 in Review

Millington Securities opened a new position in Quest Diagnostics (DGX) in Q1 2026: 6,057 shares worth $1.19M. The stake represents 0.33% of the portfolio and ranks #82 among its holdings.

1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Millington Securities held 6,057 shares of Quest Diagnostics worth $1.19M as of Q1 2026.
  • Quest Diagnostics was a new Millington Securities position in Q1 2026.
  • Quest Diagnostics made up 0.33% of Millington Securities's portfolio in Q1 2026, its #82 holding.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Millington Securities's 13F filing for Q1 2026, filed 15 Jul 2026.